#3:
Stresses the urgent need to prevent and control these diseases and, to that end, calls on the international community, especially industrialized countries, to expand, where possible, fund-raising channels and to provide adequate financial resources to countries where the diseases are endemic, especially the least developed countries, for the successful implementation of the workplans and the achievement of significant impacts in both the short and medium term, while recognizing that basic and applied research, including research on vaccines, is a priority component of such workplans.
#4:
Welcomes with satisfaction the agreement signed between Dr. Manuel Elkin Patarroyo of Colombia and the World Health Organization during the forty-eighth World Health Assembly, in May 1995, by which Dr. Patarroyo donated to the World Health Organization the licence of the patent rights and know-how related to the SPf66 anti-malarial vaccine developed by him, and stresses the importance of the World Health Organization urgently taking full advantage of this donation;
#6:
Urges the Director-General of the World Health Organization, the lead agency in international health, to continue to provide, in collaboration with the concerned United Nations agencies and programmes and within the United Nations resident coordinator system, technical expertise and support for the agreed strategies and workplans in support of national health development plans and actions in countries where these diseases are rife;
#7:
Requests the Secretary-General to submit to the Economic and Social Council at its substantive session of 1998 the report of the Director-General of the World Health Organization on the implementation of the strategies and workplans presented to the Council at its substantive session of 1995, to be prepared in collaboration with the other relevant organizations, organs, bodies and programmes of the United Nations system.